News | November 29, 2016

Arvinas Presents Data on its BET PROTAC Degraders at 2016 EORTC-NCI-AACR Symposium NEW HAVEN, Conn., November 29, 2016 – Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, today announced that data were presented...

News | November 21, 2016

Intarcia Submits New Drug Application (NDA) to FDA for U.S. Marketing Approval of ITCA 650 in Type 2 Diabetes The NDA submission reflects more than 10 years of innovation and clinical development of ITCA 650 to respond to pressing unmet needs in type 2 diabetes. ITCA...

News | November 14, 2016

UAB Medicine Selects Kyruus for Patient-Provider Matching and Provider Data Management on Nov 14, 2016 12:54:00 PM BOSTON, MA – Kyruus, a leader in provider search and scheduling solutions for health systems, announced today that UAB Medicine, one of the top four...

News | November 16, 2016

Truveris Ranked Number 131 Fastest Growing Company in North America on Deloitte’s 2016 Technology Fast 500™ Nov 16, 2016 Truveris ranked 131 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences...

News | November 7, 2016

Versartis Presents Safety, Efficacy and IGF-I Data for Somavaratan in Pediatric Growth Hormone Deficiency at the 2016 Congress of the GRS & IGF Society Increasing somavaratan dose to the 3.5mg/kg twice-monthly now used in Phase 3 safely improved IGF-I SDS and...
venenatis Donec felis mattis mattis ut dapibus Praesent porta. Aenean